Latin America Cancer Hormone Therapy Market USD 1,641.9 Million in 2024 Anticipated to Register Strong Upside Toward 2031
Expanding diagnostic capabilities are contributing to earlier detection and more timely initiation of therapy. The Latin America cancer hormone therapy market is estimated to record a CAGR of 9.5% from 2025 to 2031. Cancer hormone therapy is an essential component of oncology treatment used primarily for hormone-sensitive cancers such as breast, prostate, and endometrial cancers. In Latin...
0 Commenti 0 condivisioni 5 Views 0 Anteprima